Zobrazeno 1 - 10
of 46
pro vyhledávání: '"CLSI, Clinical and Laboratory Standards Institute"'
Autor:
Michael Neumaier, Verena Haselmann, Peter Findeisen, Margot Thiaucourt, Catharina Gerhards, Maximilian Kittel, Maria-Christina Muth
Publikováno v:
International Journal of Infectious Diseases
International Journal of Infectious Diseases, Vol 105, Iss, Pp 632-638 (2021)
International Journal of Infectious Diseases, Vol 105, Iss, Pp 632-638 (2021)
Background The detection of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is mandatory for the diagnosis, retrospective assessment of disease progression, and correct evaluation of the current infection situation in the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f998234eed80203147468f2d67d16359
https://doi.org/10.1016/j.ijid.2021.02.024
https://doi.org/10.1016/j.ijid.2021.02.024
Autor:
Ehssan H. Moglad
Publikováno v:
Saudi Journal of Biological Sciences
Saudi Journal of Biological Sciences, Vol 28, Iss 3, Pp 1835-1839 (2021)
Saudi Journal of Biological Sciences, Vol 28, Iss 3, Pp 1835-1839 (2021)
Recently, we reported high antibacterial efficiency of Loranthus acaciae (LA) against different standard strains of bacteria including Methicillin-Resistant Staphylococcus aureus (MRSA). Therefore, this study aimed to confirm the effectiveness of LA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f48671069086e15ec37a38a3c44ef8ac
https://doi.org/10.1016/j.sjbs.2020.12.029
https://doi.org/10.1016/j.sjbs.2020.12.029
Autor:
Michael Neumaier, I. Zahn, Catharina Gerhards, Maximilian Kittel, Margot Thiaucourt, Maria Christina Muth, Heinz Jürgen Roth, Peter Findeisen, Verena Haselmann
Publikováno v:
International Journal of Infectious Diseases, Vol 103, Iss, Pp 590-596 (2021)
International Journal of Infectious Diseases
International Journal of Infectious Diseases
Highlights • FDA-EUA approved anti-SARS-CoV-2 tests compare favorably with others. • longitudinal patterns of antibody development are subject to high individual variability. • comparing the assays of leading manufacturers, there are considerab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6c20c2ce256affb3eac73056819f9bc
https://doi.org/10.1016/j.ijid.2020.12.003
https://doi.org/10.1016/j.ijid.2020.12.003
Autor:
Xin-Hui Zhang, Hong-Min Liu, Yongfang Yao, Li-Ying Ma, Xue-Jian Feng, Qin Shangshang, Tingting Yu, Bing Zhao, De-Quan Yu, Xiaoling Zhang, Ying Liu
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 11, Iss 1, Pp 203-221 (2021)
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica. B
New Delhi metallo-β-lactamase-1 (NDM-1) is capable of hydrolyzing nearly all β-lactam antibiotics, posing an emerging threat to public health. There are currently less effective treatment options for treating NDM-1 positive “superbug”, and no p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c44e2471539ae24953ab00f10282f4be
http://www.sciencedirect.com/science/article/pii/S2211383520306316
http://www.sciencedirect.com/science/article/pii/S2211383520306316
Publikováno v:
Journal of Evidence Based Medicine and Healthcare, Vol 7, Iss 2, Pp 92-96 (2020)
BACKGROUND The alarming rise in carbapenem Resistance (CR) among Enterobacteriaceae is posing a great threat to the humanity, all over the world. This study is intended to evaluate the CR in a tertiary care centre in Kerala. METHODS It is a retrospec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77262ca13a49112de2ab43f090dc4b6d
https://jebmh.com/assets/data_pdf/Manoj_Gopinath_-_FINAL.pdf
https://jebmh.com/assets/data_pdf/Manoj_Gopinath_-_FINAL.pdf
Autor:
Stefan P. Kuster, Janne S. Schmidt, Vincent Perreten, Andrea Endimiani, Valentina Dazio, Michael Brilhante, Simone Schuller, Barbara Willi, Edgar I. Campos-Madueno, Stefanie Gobeli Brawand, Aurélien Nigg, Nico Mauri
Publikováno v:
Dazio, Valentina; Nigg, Aurélien; Schmidt, Janne S; Brilhante, Michael; Campos-Madueno, Edgar I.; Mauri, Nico; Kuster, Stefan P; Gobeli Brawand, Stefanie; Willi, Barbara; Endimiani, Andrea; Perreten, Vincent; Schuller, Simone (2021). Duration of carriage of multidrug-resistant bacteria in dogs and cats in veterinary care and co-carriage with their owners. One health, 13(100322), p. 100322. Elsevier 10.1016/j.onehlt.2021.100322
One Health, Vol 13, Iss, Pp 100322-(2021)
One Health
One Health, Vol 13, Iss, Pp 100322-(2021)
One Health
Background The emergence and spread of multidrug-resistant organisms (MDROs) represent a threat to human and animal health. Objectives To assess duration of carriage of MDROs in dogs and cats presented to veterinary clinics/hospitals in Switzerland.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ab831ef021103b30b05fcb0323c4692
https://boris.unibe.ch/160126/1/1-s2.0-S2352771421001129-main.pdf
https://boris.unibe.ch/160126/1/1-s2.0-S2352771421001129-main.pdf
Publikováno v:
Practical Laboratory Medicine, Vol 25, Iss, Pp e00213-(2021)
Practical Laboratory Medicine
Practical Laboratory Medicine
Objectives: Despite reports highlighting citrate association with different diseases, serum citrate is scarcely used for diagnosis. Existing methods to quantify citrate are limited by their complexity and practicality of implementation. A simple and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4a147568fd5c3225fb3704c298ad46b
http://www.sciencedirect.com/science/article/pii/S2352551721000135
http://www.sciencedirect.com/science/article/pii/S2352551721000135
Autor:
Ann Vu, John D. Zeuli, Christina G. Rivera, Zelalem Temesgen, Douglas W. Challener, F. N.U. Shweta, Kelly Pennington
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 24, Iss, Pp 100244-(2021)
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 24, Iss, Pp 100244-(2021)
Non-tuberculous mycobacteria (NTM) is a collective name given to a group of more than 190 species of Mycobacterium. The clinical presentation for most NTM infections is non-specific, often resulting in delayed diagnosis. Further complicating matters
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dec4358003828e48105943e07bbf93ae
http://europepmc.org/articles/PMC8135042
http://europepmc.org/articles/PMC8135042
Autor:
Daniel G.K. Rasmussen, Peder Frederiksen, Diana Julie Leeming, Lise Lotte Gluud, Elisabeth Erhardtsen, Jörn M. Schattenberg, Diane E. Shevell, M.A. Karsdal, Guruprasad P. Aithal
Publikováno v:
Erhardtsen, E, Rasmussen, D G K, Frederiksen, P, Leeming, D J, Shevell, D, Gluud, L L, Karsdal, M A, Aithal, G P & Schattenberg, J M 2021, ' Determining a healthy reference range and factors potentially influencing PRO-C3 – A biomarker of liver fibrosis ', JHEP Reports, vol. 3, no. 4, 100317 . https://doi.org/10.1016/j.jhepr.2021.100317
JHEP Reports, Vol 3, Iss 4, Pp 100317-(2021)
JHEP Reports
JHEP Reports, Vol 3, Iss 4, Pp 100317-(2021)
JHEP Reports
Background & Aims Progressive fibrosis has been identified as the major predictor of mortality in patients with non-alcoholic fatty liver disease (NAFLD). Several biomarkers are currently being evaluated for their ability to substitute the liver biop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d4eefdc7b3714522d884aabf5fb9f2c
https://curis.ku.dk/portal/da/publications/determining-a-healthy-reference-range-and-factors-potentially-influencing-proc3--a-biomarker-of-liver-fibrosis(c941fd32-bad0-4d92-b259-f5dc9c239ed9).html
https://curis.ku.dk/portal/da/publications/determining-a-healthy-reference-range-and-factors-potentially-influencing-proc3--a-biomarker-of-liver-fibrosis(c941fd32-bad0-4d92-b259-f5dc9c239ed9).html
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.